Economy · India
Government Caps Cancer Drug Margins, Prices May Fall Up To 70%
The Indian government has capped trade margins on non-scheduled anti-cancer drugs at 30%, a move expected to reduce prices by up to 70% and save patients an estimated ₹2,500 crore annually. Some reports indicate that in certain cases, cancer drug mark-ups had reached as high as 700%. Hospital stocks, including Fortis Healthcare, Apollo Hospitals, Max, and Medanta, saw a rise following the announcement. Brokerages suggest that while the impact on earnings might be manageable, hospital margins could face pressure.
How outlets across the spectrum covered it
L 0 C 3 R 1
- Centre (3): Business Today, Mint, The Statesman
- Right (1): Aaj Tak